featured-image

, /PRNewswire/ -- an immersive therapeutics (ITx) pioneer advancing a novel, virtual reality-based approach to medicine, today announced results from a secondary analysis of a large randomized controlled trial (RCT) that evaluated whether socio-demographic factors affected the clinical effectiveness of receiving a virtual reality (VR) therapy that treats chronic low back pain (cLBP) at home. Researchers sought to determine whether there were differences among key participant cohorts across patient-reported clinical effectiveness, therapeutic program engagement, and patient-reported VR device usability ratings. The findings, which were , found that AppliedVR's FDA-authorized produced clinically effective results that were largely invariant across age (over vs.

under 65), gender (male vs. female), race/ethnicity (Black vs. White vs.



Other) and socioeconomic (education and income) subgroups. Additionally, therapeutic program engagement was largely consistent across all socio-demographic categories and was influenced only by age where, perhaps surprisingly, older adults (65+) showed greater engagement than younger adults. Similarly, RelieVRx's usability ratings were consistently high (A+) and mostly invariant across subgroups except for some slight differences among race/ethnicity.

"Finding clinical effectiveness, therapeutic program engagement and usability to be generally consistent across socio-demographics is extremely notable because it mitigates questions surrounding how un.

Back to Health Page